Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

4.850
-0.010-0.21%
Volume:95.91M
Turnover:469.08M
Market Cap:55.99B
PE:9.14
High:5.000
Open:4.850
Low:4.810
Close:4.860
Loading ...

Alphamab Oncology's Unit Signs Licensing Agreement for Tumor Drug; Alphamab Shares Surge 39%

MT Newswires Live
·
30 Sep 2024

Stock Track | CSPC PHARMA Soars 5% on Exclusive Licensing Agreement with Jiangsu Alphamab

Stock Track
·
30 Sep 2024

BRIEF-CSPC Pharmaceutical Announces Exclusive License Agreement With Jiangsu Alphamab

Reuters
·
30 Sep 2024

CSPC Pharmaceutical - License Agreement for Development & Commercialization of Jskn003 in Mainland China

THOMSON REUTERS
·
30 Sep 2024

CSPC Pharmaceutical Gets Regulator's Nod to Conduct Clinical Trial for Hypertension Drug in China

MT Newswires Live
·
20 Sep 2024

BRIEF-CSPC Pharmaceutical Says Valsartan Levoamlodipine Maleate Tablets Get Clinical Trial Approval

Reuters
·
20 Sep 2024

CSPC Pharmaceutical - Valsartan Levoamlodipine Maleate Tablets Obtains Clinical Trial Approval

THOMSON REUTERS
·
20 Sep 2024

Stock Track | CSPC PHARMA Soars 9% After Announcing $640 Million Share Buyback Plan

Stock Track
·
20 Sep 2024

Hong Kong Stocks Head for Biggest Weekly Gain in Nearly 5 Months

South China Morning Post
·
20 Sep 2024

BUZZ-CSPC Pharmaceutical jumps most in 11 months on share buyback plan

Reuters
·
20 Sep 2024

Stock Track | CSPC PHARMA Shares Soar 6% on $5 Billion Share Buyback Plan

Stock Track
·
20 Sep 2024

BRIEF-CSPC Pharmaceutical Announces Further Share Buy-Back Plan Of Up To HK$5 Bln

Reuters
·
19 Sep 2024

CSPC Pharmaceutical Group Plans to Repurchase More Shares For Up to HK$5 Billion

MT Newswires Live
·
19 Sep 2024

Hong Kong-listed CSPC Pharmaceutical to buy back shares worth $640 mln

Reuters
·
19 Sep 2024

CSPC Pharmaceutical - Company Will Buy- Back Shares on-Market for an Aggregate of up to HK$5 Bln

THOMSON REUTERS
·
19 Sep 2024

CSPC Pharmaceutical Group Ltd - Voluntary Announcement - Further Share Buy-Back Plan of up to HK$5 Billion

THOMSON REUTERS
·
19 Sep 2024